Read More

EXCLUSIVE: Hoth Therapeutics Announces Results In Cohort 1 Of Human Clinical Trial Of BioLexa In Eczema; Says No Serious Adverse Events And No Drug-Related Treatment-Emergent Adverse Events Observed

NEW YORK, NY, September 8, 2021 /PRNewswire/ Today, Hoth Therapeutics, Inc. (NASDAQ:HOTH), a patient focused biopharmaceutical company, announced the completed safety results in Cohort 1 of its first in human clinical

HOTH

Read More

EXCLUSIVE: NextPlay Technologies Acquires AI-Powered Video Game Development Technology From Fighter Base Publishing For Total Consideration Of $5M, Which Will Be Paid By Way Of Issuing 1,666,667 Shares Of NextPlay’s Restricted Common Stock

SUNRISE, FL, August 23, 2021 – NextPlay Technologies, Inc. (NASDAQ:NXTP), a digital business ecosystem for digital advertisers, consumers, video gamers and travelers, today announced it has entered into an

NXTP